Tango Therapeutics, Inc. Share Price
NASDAQ: TNGX | Mid CapTango Therapeutics, Inc. Stock Performance
Open $28.67 | Prev. Close $28.97 | Circuit Range N/A |
Day Range $26.75 - $28.91 | Year Range $6.25 - $34.35 | Volume 1,25,033 |
Average Traded $27.24 |
Tango Therapeutics, Inc. Share Price Today
As of 10 August 2026, Tango Therapeutics, Inc.'s share price is $27.07. The stock opened at $28.67, compared to its previous close of $28.97. During today's trading session, Tango Therapeutics, Inc.'s share price traded between $26.75 and $28.91, with an average price of $27.83. Over the past 52 weeks, the stock has recorded a high of $34.35 and a low of $6.25. In terms of performance, Tango Therapeutics, Inc.'s share price has risen by 142.89% over the last six months and is up 303.43% on a year-on-year basis.
Tango Therapeutics, Inc. Share Price Chart
Tango Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $3.14B | PE Ratio (TTM) -31.11 | Dividend Yield N/A |
EPS (TTM) $-0.87 | Revenue (TTM) $62.38M | Return On Equity (TTM) -29.35% |
Profit Margin -162.85% | Debt to Equity 0.06 | Quarterly Earnings Growth YoY 154.46% |
Tango Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Tango Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Tango Therapeutics, Inc.
Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase 11 loss-of-function mutations for treating lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
Tango Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $26.73 | $27.07 | -0.48% |
Jul 2026 | $30.93 | $27.20 | -13.06% |
Jun 2026 | $21.54 | $31.29 | +42.14% |
May 2026 | $21.33 | $22.01 | +1.76% |
Apr 2026 | $21.04 | $21.63 | +3.34% |
Mar 2026 | $10.94 | $20.93 | +87.80% |
Feb 2026 | $11.76 | $11.14 | -4.17% |
Jan 2026 | $8.88 | $11.63 | +31.19% |
Dec 2025 | $10.65 | $8.87 | -18.89% |
Nov 2025 | $7.93 | $10.93 | +34.86% |
Oct 2025 | $8.49 | $8.11 | -3.51% |
Sep 2025 | $6.81 | $8.40 | +25.19% |
TNGX Share Price FAQs
What is Tango Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Tango Therapeutics, Inc. stock?
What is TNGX's market capitalisation today?
What is TNGX's net income for the last quarter?
What is the 5 year returns of TNGX?
What is the high & low stock price of TNGX today?
Can I buy TNGX shares in India?